Healthcare

Cardinal Health is a healthcare distribution giant moving medicines and medical supplies at massive scale. Earnings and cash flow have improved sharply, and specialty services add a stronger growth angle, making the company’s progress worth a closer look.

Biogen is a major neuroscience drugmaker using strong cash flow from established medicines to build new growth in Alzheimer’s disease and rare disorders. The key question is whether newer launches can turn a stabilizing business into a more durable expansion phase.

Alcon is a global eye-care specialist spanning surgical devices and contact lenses. The company combines steady demand drivers, leadership in ophthalmic surgery, and much stronger cash generation, making its long-term business profile worth a closer look.

BD supplies hospitals and labs with essential medical devices, diagnostics, and interventional products. Its broad installed base, resilient healthcare demand, and strong cash generation make it a compelling company to examine for long-term portfolio research.

argenx is a biotechnology company focused on autoimmune diseases, led by the fast-growing Vyvgart franchise. It has moved into strong profitability, operates in an expanding treatment area, and still has meaningful room to broaden its reach through new indications.

Agilent supplies essential lab instruments, consumables, software, and services used across drug development, diagnostics, and testing. High margins, recurring service revenue, and durable positions in regulated workflows make it a compelling company to examine closely.

Vertex is a biotechnology leader built on a dominant cystic fibrosis franchise that generates strong margins and billions in cash flow. The next chapter centers on turning pain, diabetes, and other pipeline programs into meaningful new revenue pillars.